Author:
Buta Marko,Džodić Radan,Đurišić Igor,Marković Ivan,Vujasinović Tijana,Markićević Milan,Nikolić-Vukosavljević Dragica
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Harbeck N, Thomssen C. A new look at node-negative breast cancer. Oncologist. 2011;16 Suppl 1:51–60. doi: 10.1634/theoncologist.2011-S1-51 .
2. Karrison TG, Ferguson DJ, Meier P. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst. 1999;91(1):80–5.
3. NCCN Clinical Practice Guidelines in Oncology (Breast Cancer Version 1.2012). 2012. Available at: http://infoonco.es/wp-content/uploads/2011/08/Breast-Cancer-V1.2012.pdf . Accessed on 28 August 2014.
4. Witzel ID, Milde-Langosch K, Wirtz RM, Roth C, Ihnen M, Mahner S, et al. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome. J Cancer Res Clin Oncol. 2010;136(11):1709–18. doi: 10.1007/s00432-010-0829-4 .
5. Harbeck N, Kates RE, Schmitt M, Gauger K, Kiechle M, Janicke F, et al. Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. Clin Breast Cancer. 2004;5(5):348–52.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献